Company Receives FDA Breakthrough Device Designation to Develop Smart Contact Lens;Partners with Palo Alto-based Vista Center for the Blind and Visually Impaired
Mojo Vision, the Invisible Computing company, today announced a pair of initiatives integral to its goal of assisting people with low or impaired vision. The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Mojo for the development of its smart contact lens. The company also announced a new partnership with Vista Center for the Blind and Visually Impaired, a Palo Alto-based nonprofit that offers rehabilitation services to more than 3,000 children and adults with blindness or impaired vision each year.
Mojo Vision is building the worlds first true smart contact lens, called the Mojo Lens. The company has been developing its smart contact lens through years of scientific research and holds numerous patents on the technology. Mojo is planning an early application of its product to help people struggling with low vision by using enhanced image overlays. These overlays provide real-time contrast and lighting enhancements, as well as zoom functionality. With its inconspicuous contact lens form factor, the Mojo Lens is designed to serve as a low vision aid that could remain discreet for the wearer and allow a hands-free experience, while delivering enhanced functional vision to assist in mobility, reading, and sighting.
At least 2.2 billion people struggle with vision impairment or blindness worldwide, but rehabilitation options and technologies to enhance their vision are very limited. For those with low or impaired vision, the ability to operate the Mojo Lens discreetly and hands-free will provide more confidence and independence in day-to-day activities like crossing intersections, identifying building entrances, navigating unfamiliar environments and interacting with others.
The FDA Breakthrough Device Program is intended to help patients receive more timely access to breakthrough technologies that have the potential to provide more effective treatment or diagnosis for life-threatening or irreversibly debilitating diseases or conditions. Under the program, the FDA will provide Mojo Vision with priority review and interactive communication regarding device development and clinical trial protocols, through commercialization. The Mojo Lens is currently in the research and development phase and is not available for sale anywhere in the world.
"Receiving the Breakthrough Device Designation is a significant step in our research and development process. We look forward to continuing our work with the FDA to ensure our solution is safe and effective, and that we can bring the Mojo Lens to market and assist people with vision impairment," said Drew Perkins, CEO of Mojo Vision. "This designation continues our work towards developing a product that can truly impact peoples lives in a positive way."
Through the partnership with Vista Center, the nonprofit organizations clients will play a direct role in providing input to the companys team of scientists and engineers, helping them define the features and capabilities of Mojos innovative technology. In turn, Mojo will be able to deliver devices to market that will contribute to vision-loss rehabilitation, and improve the quality of life for Vista Centers clients and others with similar needs. The Mojo Lens will be designed to increase contrast, highlight edges, magnify objects (like text), and zoom-out to spot check surroundings, helping people with low vision navigate the world and increase their social independence.
"Through our partnership with Mojo Vision, we have a unique opportunity to help revolutionize the way those with impaired vision are able to see the world," said Karae Lisle, Executive Director of Vista Center. "Our clients will be at the forefront of this effort, playing direct, hands-on roles in the design of Mojos technology. Together through our efforts, we hope to change the future of vision-loss rehabilitation, improve the quality of life for our clients, and pave the way for others."
Mojo Vision is led by Silicon Valley veterans from Apple, Amazon, Google, HP, Microsoft, Motorola, Infinera, Agilent, and Marvell, among others, as well as medical device and optometry experts from companies including CooperVision, Abbott, Johnson & Johnson, Medtronic, Philips Healthcare, and Zeiss Ophthalmology. Dr. Ashley Tuan, Mojos VP of medical devices and a Vista Center board member, is a Doctor of Optometry from The Ohio State University, has a PhD in Vision Science from the University of California, Berkeley, and has delivered several contact lens products. She is passionate about assisting people struggling with vision impairments.
Story continues
To find out more, go to http://www.mojo.vision.
About Mojo Vision
Mojo Vision is the Invisible Computing company, dedicated to developing products and platforms that re-imagine the intersection of ideas, information, and people. Instead of being tethered to devices that are increasingly a distraction in many aspects of our lives, Mojo envisions delivering information and knowledge that is immediate but without the disruption of traditional devices. Mojo is inventing the future of computing Invisible Computing which imagines a world where information is there when you need it, technology fades away, and you can freely connect with others in a more meaningful and confident way. Founded by technology experts with decades of experience developing pioneering products and platforms and backed by some of the worlds leading technology investors, Mojo believes the future is invisible. Mojo Vision is based in Saratoga, CA.
About Vista Center
Vista Center for the Blind and Visually Impaired, headquartered in Palo Alto, CA, is the premier regional resource nonprofit for vision loss rehabilitation services. For more than 75 years, Vista Center has served over 3,000 people annually and offers a wide range of comprehensive programs and services that empower visually impaired community members to embrace life to the fullest through evaluation, counseling, education, and training in Santa Clara, Santa Cruz, San Mateo, and San Benito counties.
We believe that vision loss need not be a barrier to independent living in the age of technology, heightened diversity, and inclusion in our community. http://www.vistacenter.org
Forward-Looking Statements:
This press release contains forward-looking statements, including, but not limited to the technical, operational, and financial benefits of Mojo Vision's solution. These statements are not guarantees of results and should not be considered as an indication of future activity or future performance. Actual results may vary materially from these expectations as a result of various risks and uncertainties.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200116005187/en/
Contacts
Brian Mast104 West Partners for Mojo Visionbrian.mast@104west.com 720-407-6060
Kim McCoy, Director of DevelopmentVista Center for the Blind & Visually Impairedkmccoy@vistacenter.org 650-858-0202
- AI has perfect detection rate for severe cases of condition that causes blindness in preemies - OHSU News - March 10th, 2024
- PulseSight launches with gene therapy platform targeting age-related blindness - Longevity.Technology - March 10th, 2024
- AIOS and RANZCO Unite to Combat Preventable Blindness - Hindustan Times - March 10th, 2024
- Baby born without eyes defies the odds as she thrives despite blindness - Express - March 10th, 2024
- Penn Medicine Accelerator Program to Boost AI-Powered Projects Targeting Blindness and Cervical Cancer - India Education Diary - March 10th, 2024
- Scientists discover gut bacteria`s role in genetically-linked vision loss - WION - February 27th, 2024
- Prevent Blindness launches new Retinopathy of Prematurity Education and Support Program as part of inaugural ... - Modern Retina - February 27th, 2024
- Revolutionizing Eye Disease Treatment: The Unseen Link Between Gut Bacteria and Blindness - Medriva - February 27th, 2024
- The Virtue of Color-Blindness & The End of Race Politics: Arguments for a Colorblind America Book Review - National Review - February 27th, 2024
- Sight loss could be treated by antibiotics after being linked to gut bacteria - The Independent - February 27th, 2024
- Prevent Blindness Launches New "Retinopathy of Prematurity (ROP) Education and Support Program" as Part of ... - PR Web - February 27th, 2024
- $35 million to fight blindness with manufactured corneas | Health Portfolio Ministers | Australian Government ... - Department of Health - February 10th, 2024
- Eye care, vision impairment and blindness - World Health Organization (WHO) - October 27th, 2023
- CHOROIDEREMIA RESEARCH FOUNDATION EXPANDS RESEARCH SUPPORT INTO NONSENSE MUTATIONS OF A RARE INHERITED RETINAL - EIN News - May 1st, 2023
- Chennai eye hospital ties up with Iceland firm to adopt mathematical algorithm to predict diabetic retinopathy - The Hindu - April 23rd, 2023
- Drug-Resistant Bacteria Tied to Eyedrops Can Spread Person to Person ... - April 7th, 2023
- Prevention of Blindness Week 2023: Mumbai experts explain why you should be concerned about glaucoma and the need for regular eye checkups -... - April 7th, 2023
- Childhood blindness - Wikipedia - February 24th, 2023
- FDA Approves Syfovre (pegcetacoplan injection) for the Treatment of ... - February 24th, 2023
- Human mini brains illuminate path to curing blindness - February 16th, 2023
- Raymond V. Gilmartin: Man with a global vision - February 16th, 2023
- Why Are People So Mad About MrBeast's Blindness Video? - February 16th, 2023
- This heartwarming video of a colorblind boy seeing color for the first time will make you cry - Indiatimes.com - February 16th, 2023
- Blindness (Vision Impairment): Types, Causes and Treatment - February 8th, 2023
- CDC urges people to stop using brand of artificial tears linked to ... - February 8th, 2023
- Health News Roundup: U.S. FDA says India-made eye drop linked to some infections, blindness and one death; China records 3,278 COVID-related deaths... - February 8th, 2023
- I had two strokes at 29 and gone blind -I've been accused of faking my sight loss - Daily Mail - February 8th, 2023
- Blindness and vision impairment - World Health Organization - January 23rd, 2023
- Recovery from blindness - Wikipedia - January 23rd, 2023
- Colour blindness tests, juggling, avoiding glare: A hockey goalkeepeers quest to train his biggest weapon, eyes - The Indian Express - January 23rd, 2023
- But Did You See the Gorilla? The Problem With Inattentional Blindness ... - October 15th, 2022
- Canadians unaware of diseases that lead to blindness, survey says - CTV News Northern Ontario - October 15th, 2022
- A Review of Corneal Blindness: Causes and Management - Cureus - October 15th, 2022
- A cure for blindness may be first product made in space - Freethink - October 15th, 2022
- Is MrBeast trying to cure 1000 people's blindness? - indy100 - October 15th, 2022
- Early detection and management is the key to prevent glaucoma related blindness: Experts - Express Healthcare - October 15th, 2022
- As World Sight Day Nears, River Blindness is Fading - SaportaReport - October 15th, 2022
- Tears of happiness: How curing blindness in Dolakha saved a girls future - City A.M. - October 15th, 2022
- World Sight Day: Orbis, UC Davis team up to train eye care teams from Latin America to fight avoidable blindness - Ophthalmology Times - October 15th, 2022
- Juan Williams: The GOPs epidemic of intentional blindness - The Hill - October 15th, 2022
- Charles pays tribute to Malawi's elimination of disease causing blindness - Express & Star - October 15th, 2022
- Coping with calamity: Former NYT columnist Frank Bruni on blindness and vision, at Morristown book fest keynote - Morristown Green - October 15th, 2022
- Sighting solutions in a world of vision for weavers - The New Indian Express - October 15th, 2022
- Blindfold run raises $40,000 for the MUHC Foundation to support glaucoma care at the MUHC - StreetInsider.com - October 15th, 2022
- MacKenzie Scott Donates $15M to Address the Eyecare Needs of the Impoverished - InvisionMag - October 15th, 2022
- Astellas and MBC BioLabs Announce Astellas Future Innovator Prize to Help Biotech Start-ups Accelerate Early Drug Discovery and Research Efforts -... - September 20th, 2022
- Treating cataracts before 'critical age' imperative FBC News - FBC News - September 20th, 2022
- GenSight Biologics to Present at Upcoming Industry and Investor Conferences - Business Wire - September 20th, 2022
- Ashton Kutcher battled vasculitis causing blindness, loss of hearing. Know all about the rare condition - India TV News - August 11th, 2022
- Prevent Blindness Is Recognized as a Healthy People 2030 Champion for Supporting the Initiative's Vision - Vision Monday - August 11th, 2022
- Researchers make progress toward a stem cellbased therapy for blindness - Ophthalmology Times - August 11th, 2022
- The strategic blindness of Israel's caretaker government - JNS.org - August 11th, 2022
- UND professor carries the torch for UND studies of visual impairment and blindness - Grand Forks Herald - August 11th, 2022
- Karan Nagrani is using social media to raise awareness about the 'spectrum of blindness' - ABC News - August 11th, 2022
- Vision impairment and blindness related to NCDs: Fong - FBC News - August 11th, 2022
- Strategic blindness of caretaker government - The Jewish Star - August 11th, 2022
- Massachusetts woman blinded by attack working to help others regain sight - WCVB Boston - August 11th, 2022
- Persuasion Film Review: Is Heterogeneous Casting Race-Inclusionary Or Escapist? - Feminism In India - August 11th, 2022
- Is It Time To Start Using Race And Gender To Combat Bias In Lending? - Forbes - August 11th, 2022
- The journey of Kali Yugi started with the mistake of objectives! - Youthistaan - August 11th, 2022
- A 50-State Review of Access to State Medicaid Program Information for People with Limited English Proficiency and/or Disabilities Ahead of the PHE... - August 11th, 2022
- iHealthScreen Completed Prospective Trial of AI-Based Tool for Age-Related Macular Degeneration (AMD) Screening and Submitting the Results to FDA for... - August 11th, 2022
- Vitamin B12: Why You Need It & Foods To Increase Your Vitamin B12 Intake - NDTV - August 11th, 2022
- Jack Levine: Remembering a dad who proved that even in blindness, there can be vision - The Florida Times-Union - June 26th, 2022
- Potion of Blindness | Minecraft Ideas Wiki | Fandom - June 26th, 2022
- Tightening a molecular "zipper" could help prevent hereditary blindness - New Atlas - June 26th, 2022
- What's the Link Between Glaucoma and Dry Eyes? - Healthline - June 26th, 2022
- Lisa Durden's upcoming documentary "Blind Divas" follows Krystle Allen and Naquela Wright-Prevoe, two Black women entrepreneurs, determined... - June 26th, 2022
- Trump election lies may fit legal concept of willful blindness - Chicago Tribune - June 26th, 2022
- Sightsavers relaunches its thematic strategy The Sun Nigeria - Daily Sun - June 26th, 2022
- Trachoma elimination: millions more to benefit from donated azithromycin - World Health Organization - June 26th, 2022
- Dangers of super gonorrhoea from infertility to blindness as global warning issued - Daily Star - June 26th, 2022
- Fifty years of Title IX: What is it, what does it cover and do we still need it? - The Athletic - June 26th, 2022
- How The SMH Got That Rebel Wilson Story So Wrong - Junkee - June 26th, 2022
- The Week That Was: All of Lawfare in One Post - Lawfare - Lawfare - June 26th, 2022
- Why Brad Pitt quit smoking and drinking altogether during the pandemic - BusinessGhana - June 26th, 2022
- Watch your eye - The New Indian Express - June 26th, 2022
- Olivia Brouwer's art is for everyone to see and touch - Hamilton Spectator - June 26th, 2022
- Monkeypox may not mutate as fast as coronaviruses, but that doesn't mean it can't adapt to its new hosts - The Conversation - June 26th, 2022
- Former American Express Foundation President Takes Helm of Signature Theatre - The Chronicle of Philanthropy - June 26th, 2022